QS Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $7.46M | Sell |
108,269
-19,801
| -15% | -$1.32M | 0.09% | 167 |
|
|
2021
Q1 | $8.28M | Sell |
128,070
-1,622
| -1% | -$105K | 0.1% | 162 |
|
|
2020
Q4 | $7.56M | Sell |
129,692
-192,094
| -60% | -$11.6M | 0.09% | 164 |
|
|
2020
Q3 | $20.3M | Buy |
321,786
+23,899
| +8% | +$1.66M | 0.27% | 51 |
|
|
2020
Q2 | $22.9M | Buy |
297,887
+192,302
| +182% | +$14.7M | 0.32% | 45 |
|
|
2020
Q1 | $7.89M | Sell |
105,585
-38,618
| -27% | -$2.67M | 0.13% | 136 |
|
|
2019
Q4 | $9.41M | Sell |
144,203
-3,712
| -3% | -$242K | 0.09% | 159 |
|
|
2019
Q3 | $9.38M | Buy |
147,915
+5,508
| +4% | +$360K | 0.1% | 151 |
|
|
2019
Q2 | $9.62M | Buy |
142,407
+18,913
| +15% | +$1.24M | 0.1% | 129 |
|
|
2019
Q1 | $8.03M | Sell |
123,494
-10,672
| -8% | -$709K | 0.09% | 148 |
|
|
2018
Q4 | $8.39M | Sell |
134,166
-112,495
| -46% | -$7.86M | 0.11% | 128 |
|
|
2018
Q3 | $19M | Sell |
246,661
-6,107
| -2% | -$461K | 0.18% | 70 |
|
|
2018
Q2 | $17.9M | Sell |
252,768
-524
| -0.2% | -$37K | 0.18% | 74 |
|
|
2018
Q1 | $19.1M | Sell |
253,292
-3,084
| -1% | -$245K | 0.2% | 64 |
|
|
2017
Q4 | $18.4M | Sell |
256,376
-4,088
| -2% | -$310K | 0.17% | 71 |
|
|
2017
Q3 | $21.1M | Sell |
260,464
-9,927
| -4% | -$759K | 0.17% | 84 |
|
|
2017
Q2 | $19.1M | Sell |
270,391
-19,484
| -7% | -$1.3M | 0.16% | 83 |
|
|
2017
Q1 | $19.7M | Sell |
289,875
-240,763
| -45% | -$16.9M | 0.17% | 81 |
|
|
2016
Q4 | $38M | Sell |
530,638
-115,674
| -18% | -$8.6M | 0.31% | 56 |
|
|
2016
Q3 | $51.1M | Sell |
646,312
-19,105
| -3% | -$1.55M | 0.4% | 37 |
|
|
2016
Q2 | $55.5M | Sell |
665,417
-5,800
| -0.9% | -$515K | 0.47% | 33 |
|
|
2016
Q1 | $61.7M | Buy |
671,217
+200,967
| +43% | +$18.1M | 0.59% | 24 |
|
|
2015
Q4 | $47.6M | Sell |
470,250
-154,098
| -25% | -$16M | 0.46% | 33 |
|
|
2015
Q3 | $61.3M | Sell |
624,348
-1,588
| -0.3% | -$176K | 0.64% | 20 |
|
|
2015
Q2 | $73.3M | Buy |
625,936
+113,197
| +22% | +$12.4M | 0.9% | 14 |
|
|
2015
Q1 | $50.3M | Sell |
512,739
-118,188
| -19% | -$12M | 0.57% | 26 |
|
|
2014
Q4 | $59.5M | Buy |
630,927
+207,604
| +49% | +$21.5M | 0.69% | 19 |
|
|
2014
Q3 | $45.1M | Buy |
423,323
+69,250
| +20% | +$6.78M | 1.21% | 18 |
|
|
2014
Q2 | $29.4M | Sell |
354,073
-117,900
| -25% | -$9.18M | 0.79% | 26 |
|
|
2014
Q1 | $33.4M | Buy |
471,973
+410,400
| +667% | +$32.2M | 1.01% | 22 |
|
|
2013
Q4 | $4.63M | Sell |
61,573
-800
| -1% | -$55.7K | 0.18% | 124 |
|
|
2013
Q3 | $3.92M | Sell |
62,373
-12,227
| -16% | -$731K | 0.17% | 143 |
|
|
2013
Q2 | $3.89M | Buy |
+74,600
| New | +$3.89M | 0.14% | 201 |
|
Other funds holding GILD
QS Investors's GILD Position: Q2 2021 in Review
QS Investors reduced its Gilead Sciences (GILD) stake by 15% in Q2 2021, selling an estimated $1.32M and leaving 108,269 shares worth $7.46M. The position accounts for 0.09% of the portfolio, ranked #167.
QS Investors first reported a position in GILD in Q2 2013 and has held it in 33 quarters since. The position peaked at $73.3M in Q2 2015. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.
- QS Investors held 108,269 shares of Gilead Sciences worth $7.46M as of Q2 2021.
- QS Investors sold 19,801 Gilead Sciences shares in Q2 2021, an estimated $1.32M.
- Gilead Sciences made up 0.09% of QS Investors's portfolio in Q2 2021, its #167 holding.
- QS Investors first reported a position in Gilead Sciences in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Gilead Sciences position peaked at $73.3M in Q2 2015.
- 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.